[{"AccountsPayableCurrent_0_Q3_USD":16543000.0,"OtherLiabilitiesCurrent_0_Q3_USD":9267000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-272000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-38000.0,"OtherAssetsNoncurrent_0_Q3_USD":670000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":25071000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":24574000.0,"OperatingIncomeLoss_3_Q3_USD":-247059000.0,"OperatingIncomeLoss_1_Q3_USD":-84812000.0,"OperatingExpenses_3_Q3_USD":259851000.0,"OperatingExpenses_1_Q3_USD":90182000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2215000.0,"NetIncomeLoss_3_Q3_USD":-246792000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-186253000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":46582000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":52476000.0,"LiabilitiesCurrent_0_Q3_USD":86150000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":449923000.0,"Liabilities_0_Q3_USD":139782000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-1251000.0,"InterestReceivable_0_Q3_USD":400000.0,"InterestPaidNet_3_Q3_USD":25000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-10841000.0,"NetIncomeLoss_1_Q3_USD":-84664000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":148000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":283000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1244000.0,"StockholdersEquity_0_Q3_USD":310141000.0,"ShortTermInvestments_0_Q3_USD":244036000.0,"ShareBasedCompensation_3_Q3_USD":39837000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":13427000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1371373000.0,"RestrictedCashNoncurrent_0_Q3_USD":1200000.0,"RestrictedCashCurrent_0_Q3_USD":194000.0,"RestrictedCash_0_Q3_USD":1400000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":202867000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":70333000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":53485000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":79808000.0,"ProfitLoss_3_Q3_USD":-246792000.0,"ProceedsFromStockPlans_3_Q3_USD":5190000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_3_Q3_USD":279450000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-17000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":48739000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":12058000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":224754000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":8114000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-27000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":93602000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":201000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-1318000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-87195000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":114603000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":113209000.0,"CapitalUnitsAuthorized_0_Q3_shares":520000000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1858000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":355058000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":299320000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":299282000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q3_USD":355034000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":21441111.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":55738000.0,"AssetsCurrent_0_Q3_USD":369497000.0,"Assets_0_Q3_USD":449923000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":14253437.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":39837000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":13762000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":13762000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1681481000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":24000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":26323000.0,"AccretionExpense_3_Q3_USD":64000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q3_USD":55752000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockSharesIssued_0_Q3_shares":88387000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":-3182000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-1250000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":8710000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":16000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxesPaidNet_3_Q3_USD":16000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-246776000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-84664000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":56984000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":19849000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":0.0,"FinanceLeasePrincipalPayments_3_Q3_USD":192000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":19140000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.67,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.9,"DepreciationAndAmortization_3_Q3_USD":6857000.0,"DepreciationAndAmortization_1_Q3_USD":2300000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":26843000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":31226000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-247064000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-84702000.0,"CommonStockValue_0_Q3_USD":9000.0,"CommonStockSharesOutstanding_0_Q3_shares":88387000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":1859000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":92411000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]